Identification of Allobaculum mucolyticum as a novel human intestinal mucin degrader by Muijlwijk, Guus H. van et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2021-11-02 and may be subject to
change.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=kgmi20
Gut Microbes
ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/kgmi20
Identification of Allobaculum mucolyticum as a
novel human intestinal mucin degrader
Guus H. van Muijlwijk, Guido van Mierlo, Pascal W.T.C. Jansen, Michiel
Vermeulen, Nancy M.C. Bleumink-Pluym, Noah W. Palm, Jos P.M. van Putten
& Marcel R. de Zoete
To cite this article: Guus H. van Muijlwijk, Guido van Mierlo, Pascal W.T.C. Jansen, Michiel
Vermeulen, Nancy M.C. Bleumink-Pluym, Noah W. Palm, Jos P.M. van Putten & Marcel R.
de Zoete (2021) Identification of Allobaculum mucolyticum as a novel human intestinal mucin
degrader, Gut Microbes, 13:1, 1966278, DOI: 10.1080/19490976.2021.1966278
To link to this article:  https://doi.org/10.1080/19490976.2021.1966278
© 2021 The Author(s). Published with
license by Taylor & Francis Group, LLC.
View supplementary material 
Published online: 30 Aug 2021. Submit your article to this journal 
Article views: 474 View related articles 
View Crossmark data
RESEARCH PAPER
Identification of Allobaculum mucolyticum as a novel human intestinal mucin 
degrader
Guus H. van Muijlwijk a, Guido van Mierlo b,e, Pascal W.T.C. Jansenb, Michiel Vermeulen b, Nancy M. 
C. Bleumink-Pluymc, Noah W. Palm d, Jos P.M. van Putten c, and Marcel R. de Zoete a
aDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands; bDepartment of Molecular Biology, Faculty of 
Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Nijmegen, The Netherlands; 
cDepartment of Biomolecular Health Sciences, Utrecht University, Utrecht, Netherlands; dDepartment of Immunobiology, Yale University 
School of Medicine, New Haven, CT, USA; eLaboratory of Systems Biology and Genetics, Institute of Bioengineering, School of Life Sciences, 
Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne CH-1015, Switzerland
ABSTRACT
The human gut microbiota plays a central role in intestinal health and disease. Yet, many of its 
bacterial constituents are functionally still largely unexplored. A crucial prerequisite for bacterial 
survival and proliferation is the creation and/or exploitation of an own niche. For many bacterial 
species that are linked to human disease, the inner mucus layer was found to be an important niche. 
Allobaculum mucolyticum is a newly identified, IBD-associated species that is thought be closely 
associated with the host epithelium. To explore how this bacterium is able to effectively colonize 
this niche, we screened its genome for factors that may contribute to mucosal colonization. Up to 
60 genes encoding putative Carbohydrate Active Enzymes (CAZymes) were identified in the 
genome of A. mucolyticum. Mass spectrometry revealed 49 CAZymes of which 26 were significantly 
enriched in its secretome. Functional assays demonstrated the presence of CAZyme activity in 
A. mucolyticum conditioned medium, degradation of human mucin O-glycans, and utilization of 
liberated non-terminal monosaccharides for bacterial growth. The results support a model in which 
sialidases and fucosidases remove terminal O-glycan sugars enabling subsequent degradation and 
utilization of carbohydrates for A. mucolyticum growth. A. mucolyticum CAZyme secretion may thus 
facilitate bacterial colonization and degradation of the mucus layer and may pose an interesting 
target for future therapeutic intervention.
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The intestinal microbiota plays an important role in 
host health and disease. Due to their close associa-
tion with the host epithelium, bacteria occupying 
the intestinal mucosal niche are thought to have 
a preponderant effect on host health. For example, 
their close proximity to the intestinal epithelium 
increases the chances of activating host immune 
responses, which may drive excessive inflammatory 
responses as seen in inflammatory bowel disease 
(IBD).1
In order to provide protection and avoid exces-
sive inflammatory responses, the intestinal epithe-
lial cells are covered by a viscous mucus layer that 
protects them from direct contact with potentially 
harmful bacteria. This mucus layer primarily con-
sists of heavily glycosylated mucin proteins, such as 
MUC2, that are highly decorated with branched 
O-glycans linked to serine/threonine-rich repeats 
in the polypeptide backbone. These mucin 
O-glycans retain large amounts of water (>90% of 
the mucin weight is due to water), which gives the 
mucus layer its lubricant properties. Furthermore, 
mucin glycans also protect the peptide backbone 
from proteolytic degradation by bacterial and host 
proteases, thereby safeguarding its main function as 
a mucosal firewall.
Many enteropathogenic bacteria have developed 
mechanisms to breach the mucus barrier, e.g. 
through flagella-driven propulsion. However, in 
recent years it has also become clear that several 
commensal bacteria, such as Akkermansia mucini-
phila and Bacteroides thetaiotamicron, have 
adopted a mucus-dwelling lifestyle and feed on 
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the monosaccharides present in mucin O-glycans.2– 
5 To enable this, these bacteria employ one or more 
mucin O-glycan specific glycoside hydrolases that 
release the monosaccharides that make up the gly-
can chain. The glycoside hydrolase families 
required for mucin O-glycan degradation have pre-
viously been described by Tailford et al.6
A decreased mucus layer thickness and increased 
bacterial invasion into the inner mucus layer are 
well-known phenomena in IBD pathology.7 Our 
group has previously demonstrated that IgA- 
coated bacteria are inclined to encroach toward 
the intestinal epithelial cells and can cause intest-
inal inflammation in mouse models of colitis.8 One 
of these highly IgA-coated bacteria is a newly iden-
tified bacterium from the Allobaculum genus: 
Allobaculum mucolyticum sp. nov. Little is known 
about bacteria from the Allobaculum genus, which 
are part of the Erysipelotrichaceae family and inha-
bitants of the intestinal microbiota. The first 
reported member of this genus is Allobaculum ster-
coricanis, a Gram-positive rod shaped bacterium 
isolated from dog feaces.9 Allobaculum species are 
mainly identified on the basis of high throughput 
16S rRNA gene sequencing, often in studies that 
focus on changes in gut microbiota composition of 
mice after dietary interventions. The relative abun-
dance of Allobaculum species in mice and rats has 
been correlated with aging, high fat diets, and fatty 
acid metabolism.10–16 Besides correlations with 
fatty acid metabolism, Herrmann et al. reported 
Allobaculum to be an active glucose utilizer and 
producer of lactate and butyrate.13,14 These reports 
are in line with previous reports about bacteria 
from the Erysipelotrichaceae family, which are 
often associated with a western or high fat diet.17,18
Allobaculum species have also been implicated 
in playing a role in inflammatory processes. For 
example, Cox et al.16 reported a positive correla-
tion between Allobaculum relative abundance and 
levels of ileal RORγT and IL-17 levels and protec-
tion from metabolic syndrome in mice. Another, 
more recent report by Miyauchi et al. causatively 
linked an Allobaculum strain (OTU002) to 
increased susceptibility to experimental autoim-
mune encephalitis.19 This was attributed to this 
bacterium’s ability to adhere to small intestinal 
epithelial cells which induces the expansion of 
inflammatory intestinal T helper 17 cells. Finally, 
A. mucolyticum was originally isolated from an 
ulcerative colitis patient (UC) based on its high 
levels of IgA coating. Mice that were colonized 
with this strain as part of a microbial community 
also developed IgA responses toward this bacter-
ium and developed much more severe colitis upon 
exposure to DSS.8 This suggests that 
A. mucolyticum is immunogenic in vivo and 
could play an important role in the development 
of intestinal inflammation.
As the reports about Allobaculum species are 
increasing in number, and we and others have 
reported that bacteria within the Allobaculum 
genus belong to the immunogenic inhabitants of 
the intestinal mucosal niche, a more detailed char-
acterization of bacteria belonging to this genus is 
warranted. Here, we subjected A. mucolyticum to 
a thorough genomic and functional characteriza-
tion. We show that A. mucolyticum can secrete 
a wide repertoire of mucin O-glycan targeting car-
bohydrate active enzymes (CAZymes), which allow 
it to effectively degrade and feed on intestinal 
mucins. These potent mucolytic capabilities suggest 
it can effectively colonize and degrade the protec-
tive mucus layer of its host.
Results
Allobaculum mucolyticum utilizes both dietary- and 
host-derived glycans for growth
Allobaculum species are inhabitants of the intes-
tine and thus encounter multiple dietary- and 
host-derived nutrients. To investigate the nutri-
ent requirements of A. mucolyticum, we assessed 
its growth over a period of 72 hours in the pre-
sence of a variety of substrates. Robust growth of 
A. mucolyticum was observed in an enriched gut 
microbiota medium (GMM), containing multiple 
mono- and disaccharides, such as glucose, fruc-
tose, maltose and cellobiose (Figure 1a). To 
examine whether other, dietary-derived sources 
of glycan can also be used for growth, 
A. mucolyticum was grown in a basal medium 
supplemented with the plant polysaccharide inu-
lin (Figure S1). The basal medium alone, which 
lacks all glycans present in GMM, did not sup-
port the growth of A. mucolyticum. 
Supplementation of basal medium with inulin 










































































































































































































































































































































































































































































































































































































































































resulted in firm growth, demonstrating the bac-
terium’s ability to utilize dietary-derived carbon 
sources.
As several other Allobaculum species have been 
reported to be closely associated with the intestinal 
mucosal niche we next investigated whether 
A. mucolyticum could also use mucins for growth. 
Hereto, basal medium was supplemented with por-
cine gastric mucin (PGM, 0.5% w/vol) and this was 
sufficient to support A. mucolyticum growth 
(Figure 1a). To assess whether mucin O-glycans 
and/or the mucin peptide backbone peptide pro-
moted bacterial growth, bacteria were grown in 
basal medium supplemented with purified mucin 
O-glycans (10 mg/mL). After supplementation with 
these glycans A. mucolyticum was able to grow to 
a similar optical density as on complete porcine 
gastric mucin (0.5% w/vol) (Figure 1a). This 
showed that the O-glycans present on mucin are 
sufficient to support the growth of A. mucolyticum 
and indicates that it can, in addition to dietary- 
derived glycans, also use host-derived mucin as 
a growth substrate.
The genome of Allobaculum mucolyticum pre-
dicts the presence of a wide range of O-glycan- 
targeting carbohydrate active enzymes 
(CAZymes)
To investigate how A. mucolyticum can utilize 
complex O-glycans, we interrogated the available 
A. mucolyticum genome for the presence of carbo-
hydrate active enzymes (CAZymes) using the 
dbCAN2 metaserver pipeline for automated 
CAZyme annotation.20 This pipeline uses 
a combination of three different annotation tools 
(Diamond, HMMER and Hotpep) to increase accu-
racy in predicting and annotating CAZymes within 
bacterial genomes. This analysis revealed a total of 
102 putative ORFs with putative CAZy domains 
(Figure 1b).
For increased accuracy, we discarded hits that 
were not identified by at least two out of three 
tools for further analysis. Among the remaining 
60 ORFs multiple types of CAZy domains could 
be detected, such as glycoside hydrolase (GH), car-
bohydrate esterase (CE), glycosyl transferase (GT) 
domains, and carbohydrate-binding modules 
(CBM), with some genes encoding a combination 
of multiple domains (Figure 2c). Many of the ORFs, 
especially those containing glycoside hydrolase 
domains, also encode signal peptides, suggesting 
that the proteins may be transferred to the bacterial 
surface or secreted into the environment. The wide 
repertoire of secreted and non-secreted CAZymes 
suggests that A. mucolyticum is highly adapted to 
living in the glycan-rich mucus niche.
Closer inspection of the collection of CAZymes 
identified in the A. mucolyticum genome revealed 
at least 22 glycoside hydrolases that were predicted 
to specifically target O-glycans as found on 
mucins, of which the majority contains a signal 
peptide (Table 1). Among the 22 glycoside hydro-
lases are two sialidases (GH33) and three fucosi-
dases (GH29/95), which target the 
monosaccharides often found at terminal posi-
tions of mucin O-glycans, and eight different 
galactosidases (GH2) and nine hexosaminidases 
(GH20/GH84/GH89), which are predicted to 
hydrolyze the underlying glycosidic linkages. The 
gene structure of the 22 putative enzymes, with 
the locations of the predicted glycoside hydrolase 
domains and additional domains (Figure 2), 
clearly demonstrates the great diversity in 
domains, domain organization and predicted pro-
tein sizes – also between genes predicted to encode 
the same class of enzymes. Transcription and 
translation of the entire repertoire of mucin- 
targeting CAZymes would allow degradation of 
the wide variety of linkages commonly found 
within mucin O-glycans.
A. mucolyticum secretes a large array of mucin 
O-glycan-targeting CAZymes
In order to establish which of the predicted 
mucin-targeting CAZymes is produced and 
secreted by A. mucolyticum under in vitro cultur-
ing conditions, both the bacterial whole-cell lysate 
and the conditioned medium from bacteria cul-
tured for 24 h in complete GMM were subjected 
to proteomic analysis using mass spectrometry. In 
addition, the conditioned media from bacteria 
grown for 24 h in basal medium or basal medium 
supplemented with PGM were analyzed to inves-
tigate the effect of glycan availability on the reg-
ulation or secretion of CAZymes. Mapping of the 
detected peptide fragments to the A. mucolyticum 
genome revealed a total of 1005 proteins in the 
whole-cell lysate and the different conditioned 
media fractions. Since A. mucolyticum has 










































































































































































































































a predicted 2255 genes, these results show that 
nearly 45% of all genes are translated under the 
conditions tested.
Since many CAZymes contain putative signal 
peptides and are predicted to be secreted, we next 
analyzed the total A. mucolyticum secretome by 
focusing on proteins enriched in the conditioned 
media compared to the whole-cell lysate. This 
showed that 86 proteins were significantly enriched 
(>10 fold) in the conditioned medium of at least one 
of the three different growth conditions (Figure S2). 
For most proteins, the highest enrichment was 
detected in the conditioned medium of bacteria 
grown in GMM. Basal medium supplemented with 
PGM largely mimicked the protein secretion profile 
of complete GMM, suggesting that PGM provides 
similar regulatory cues or secretion signals. Basal 
medium did not result in a large number of signifi-
cantly enriched secreted proteins, which correlated 
with the poor growth in this medium.
A closer inspection of the detected proteins 
revealed that out of the 60 putative CAZymes iden-
tified in the genome, 49 were detected using mass 
spectrometry of which 26 were significantly enriched 
in the conditioned medium of at least one of the 
growth conditions (Figure S3). Eighteen of these 
were predicted mucin-targeting CAZymes 
(Figure 3), indicating that over 80% (18 out of 22) 
of the predicted mucin-targeting CAZymes were 
produced and secreted into the culture media. 
Strikingly, the 18 mucin-targeting CAZymes were 
among the most abundant proteins detected. This 
analysis demonstrates that A. mucolyticum produces 
and secretes a large array of putative mucin O-glycan 
targeting glycoside hydrolases which together are 
predicted to efficiently deglycosylate mucin proteins.
Functional activity of the secreted CAZymes
Mucin O-glycans, such as the typical core 2 mucin 
O-glycan depicted in figure 5f, are made up of 
multiple covalently linked monosaccharides. To 
degrade such glycans the linkages between the dif-
ferent monosaccharides need to be hydrolyzed by 
CAZymes with the correct linkage specificity. To 
verify whether the CAZymes secreted by 
A. mucolyticum are enzymatically active and able 
to hydrolyze linkages found in mucin O-glycans, 
conditioned medium or heat-inactivated condi-
tioned medium (30 minutes at 98°C) from a 48 h 
culture was incubated with five different monova-
lent fluorescent or chromogenic substrates to detect 
the presence of sialidase, fucosidase, galactosidase, 
N-acetyl-glucosaminidase and N-acetyl-galactosa-
minidase activities. This resulted in clear signals 
for the presence of α-sialidase, β-galactosidase, β- 
GlcNAcase and α-GalNAcase activities in 
A. mucolyticum conditioned medium (Figure 4a- 
e). Although multiple fucosidases were detected in 
the secretome during the proteomics analysis, no 
fucosidase activity could be detected – even after 
Table 1. Putative mucin O-glycan targeting CAZymes of A. mucolyticum.
Specificity Gene_ID (putative activity) CAZy family domainsa Signal peptide (aa) Protein size (aa)
Sialidase Allo_00594 (exo-α-sialidase) CBM40,CBM40,GH33,CBM32 Y(1-25) 1762
Allo_01388 (exo-β-N-acetylgalactosaminidase, exo-α-sialidase) GH123,GH33 Y(1-25) 1765
Fucosidase Allo_00589 (exo-α-1,2-L-fucosidase) GH95,CBM51 Y(1-29) 1675
Allo_01711 exo-α-1,2-L-fucosidase) GH95,CBM51 Y(1-29) 1234
Allo_01759 (exo-α-1,3/1,4-L-fucosidase) GH29 Y(1-30) 1011
Galactosidase Allo_00211 (exo-β-galactosidase) GH2,CBM51,CBM67 N 1203
Allo_00263 (exo-β-galactosidase) GH2,CBM51,CBM51 N 1772
Allo_00420 (exo-β-galactosidase) CBM32,GH2 Y(1-20) 1626
Allo_00471 (exo-β-galactosidase) GH2,CBM32,CBM67,CBM71 Y(1-39) 1671
Allo_00653 (exo-β-galactosidase) GH2,CBM32,CBM67,CBM71 Y(1-35) 1545
Allo_01151 (exo-β-galactosidase) GH2,CBM57 N 761
Allo_01556 (exo-β-galactosidase) GH2,GH2 Y(1-28) 2555
Allo_02061 (exo-β-galactosidase) GH2,GH2 Y(1-31) 1766
Hexosaminidase Allo_00011 (exo-α-N-acetylglucosaminidase) GH89,CBM32 Y(1-33) 1532
Allo_00472 (exo-α-N-acetylglucosaminidase) GH89 Y(1-33) 1468
Allo_00591 (exo-β-N-acetylglucosaminidase) GH84,CBM32 Y(1-42) 1117
Allo_00701 (β-N-acetylglucosaminidase) GH20 Y(1-24) 1042
Allo_01227 (exo-β-N-acetylglucosaminidase) GH84,CBM32 Y(1-29) 1422
Allo_01229 (exo-β-N-acetylglucosaminidase) GH84,CBM32 Y(1-29) 1407
Allo_01236 (exo-β-N-acetylglucosaminidase) GH84,CBM32 Y(1-29) 514
Allo_01836 (β-N-acetylglucosaminidase) CBM32,CBM32,GH20,CBM32 Y(1-35) 1567
Allo_01981 (β-N-acetylglucosaminidase) GH84,CBM32,CBM32 Y(1-27) 1528
aIdentified domains are listed from N to C terminus of the peptide chain
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Figure 3. Mass spectrometry analysis of the A. mucolyticum proteome demonstrates the presence of mucin O-glycan targeting 
CAZymes. Conditioned media (CM) from 24 h cultures in basal medium (BM), basal medium + PGM and Gut Microbiota Medium 
(GMM) and a whole cell lysate (WCL) from the GMM culture were subjected to mass spectrometry analysis, with three biologically 
independent replicates per condition. (a) The scatter plots show the log2 LFQ from whole cell lysate of the GMM culture (X-axis) and 
the secretomes from the three different media (Y-axis). The colored dots indicate the putative O-glycan targeting CAZymes with their 
color matching the color of their putative CAZyme class shown in the heat map. (b) The red/blue heat map displays the proteins and 
their relative enrichment in the three different secretomes compared to the GMM WCL. Significance (depicted in the brown heatmap) 
was calculated using a t-test and indicates a > 10 fold enrichment in the respective secretome versus GMM WCL with an FDR < 0.05.
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concentrating the culture media 100x. An alterna-
tive approach using chemoselective labeling of the 
fucosidases with an activity-based probe, which can 
detect fucosidase activity in enzymes with both 
GH29 and GH95 glycosyl hydrolase domains, also 
did not detect fucosidase activity. Despite the lack 
of fucosidase activity, the combination of identified 
enzymatic activities would likely be able to effec-
tively target and degrade O-linked glycans, such as 
found on mucins.
Mucin degradation and utilization by 
A. mucolyticum
To assess whether secreted CAZymes in the 
A. mucolyticum conditioned medium are sufficient 
to degrade mucins, porcine gastric mucin (10 mg/ 
mL) and human intestinal mucin (10 mg/mL) were 
treated with either control GMM, A. mucolyticum 
conditioned medium or heat-inactivated conditioned 
medium (30 min, 98°C). Following incubation (18 h), 
the mucins were separated using SDS-PAGE and 
Figure 4. Enzymatic activity of mucin O-glycan-targeting CAZymes in conditioned medium of A. mucolyticum. Filter-sterilized 
conditioned medium (CM) from a 48 h culture of A. mucolyticum grown in Gut Microbiota Medium was incubated for two hours at 
37°C with fluorescent 4-methylumbelliferone linked (a) α-N-acetylneuraminic acid (sialic acid), (b) α-fucose, (d) β-GlcNAc and (e) α- 
GalNAc or the chromogenic substrate (c) 2-Nitrophenyl β-D-galactopyranoside (ONPG) for the detection of enzymatic activities. A 100x 
concentrated conditioned medium was used with the α-fucose substrate. (f) Schematic composition of a typical core 2 mucin O-glycan 
and the target site for each enzyme class. Data represent the mean ± SD of three independent experiments. Statistical significance was 
determined by an unpaired t test using GraphPad Prism software. **, P < .01; ***, P < .001; ****, P < .0001; ns, not significant.
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then either stained in-gel with a Periodic acid-Schiff 
stain (PAS) or electroblotted onto a nitrocellulose 
membrane and detected with a SNA lectin or an 
antibody against human MUC2. The PAS-based 
detection, which detects polysaccharides, clearly 
demonstrated that both the porcine gastric mucin 
(Figure 5a) and human intestinal mucin (Figure 5b) 
were almost entirely degraded by the A. mucolyticum 
conditioned medium. Heat-inactivation completely 
abolished the mucin degradation activity. When 
detecting sialic acids at terminal positions in the 
glycan chain by probing with the lectin SNA, a clear 
reduction in signal upon treatment with conditioned 
medium was observed (Figure 5a-b). Interestingly, 
human intestinal mucin, which according to the 
PAS stain barely entered the gel, appeared as 
a MUC2-positive smear after treatment with the 
active conditioned medium. The smear pattern indi-
cates degradation of MUC2 and an enhanced ability 
to be separated by SDS-PAGE.
To assess whether mucin O-glycans products could 
be used as a substrate for bacterial growth, 
A. mucolyticum was cultured in a basal medium sup-
plemented with 20 mM of the individual monosac-
charides that are typically found within O-glycan 
chains: sialic acid, fucose, galactose, GlcNAc and 
GalNAc (Figure 6). The addition of sialic acid or 
fucose to basal medium did not support growth. In 
contrast, galactose, GlcNAc and GalNAc did support 
growth equal to growth levels observed in complete 
GMM. As sialic acid and fucose normally cap the 
O-glycans and protect the glycan chain from hydro-
lysis, this finding supports a model in which 
A. mucolyticum produces sialidases and fucosidases 
in order to gain access to and liberate underlying 
galactose, GlcNAc and GalNAc. Overall these data 
demonstrate that A. mucolyticum can effectively 
degrade mucin O-glycans by secreting a wide reper-
toire of mucin degrading enzymes after which it can 
use the liberated galactose, GlcNAc and GalNAc as 
substrates for growth.
Discussion
While the intestinal mucus layer is designed as 
a barrier against bacterial invasion some bacteria 
have adapted to living in the mucosal niche by feeding 
on mucin glycans. Through close proximity to intest-
inal epithelial cells these bacteria can have a dominant 
effect on host physiology and intestinal immune 
responses. Here we provide evidence that the recently 
classified bacterium Allobaculum mucolyticum pro-
duces a large repertoire of mucin O-glycan targeting 
enzymes that allow it to degrade mucins and forage 
on host-derived mucin O-glycans.
A search of CAZymes encoded in the 
A. mucolyticum genome revealed an array of 60 
putative CAZymes of which many can target 
mucin O-glycans. With multiple glycoside hydro-
lases predicted to target similar glycosidic 
Figure 5. Enzymatic activity within A. mucolyticum conditioned medium degrades porcine and human mucins. (a) Porcine gastric 
mucin or (b) human intestinal mucin (both 10 mg/mL) were mixed 1:1 with GMM (mock) or active or heat-inactivated A. mucolyticum 
conditioned medium (CM) from a 48 h culture grown in GMM, and incubated overnight at 37°C. After separation using SDS-PAGE, 
mucins were either detected in-gel using a Period acid-Schiff (PAS) stain or electroblotted and detected using SNA lectin, and in the 
case of human intestinal mucin also with an anti-MUC2 antibody. Molecular masses are indicated in kilodaltons (kDa).
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linkages, there appears to be a considerable redun-
dancy in the A. mucolyticum CAZyme repertoire. 
For example, there are eight putative β- 
galactosidases and eight different hexosamini-
dases. Closer inspection of the proteins revealed 
that both the domain architecture and organiza-
tion (Figure 2) and levels of protein production 
(Figure 3) are markedly different between different 
CAZymes that are predicted to target the same 
linkage. This redundancy may be explained by 
placing it in the perspective of the incredible 
diversity of glycans and glycan-linkages present 
in intestinal mucosal niche. Mucin glycans can 
be branched and contain various structures and 
modifications, which can greatly affect enzyme- 
substrate interactions. Having a diverse repertoire 
of CAZymes therefore allows A. mucolyticum to 
utilize a wide range of glycan substrates.
Large repertoires of CAZymes are also found in 
the genomes of other well-known mucolytic bacteria 
such as Akkermansia muciniphila, Ruminococcus 
gnavus, Ruminococcus torques and several 
Bifidobacteria and Bacteroides species, such as 
Bacteroides thetaiotamicron.6 Glycan generalists 
such as B. fragilis and B. thetaiotamicron contain 
a very extensive repertoire of CAZymes, which 
allows utilization of a wide variety of substrates 
from both dietary- and host-derived sources. The 
total repertoire of CAZymes encoded within the 
A. mucolyticum genome is not as extensive as that 
of certain Bacteroides species, but A. mucolyticum 
seems to be highly specialized to target mucin 
O-glycans, with more than nearly half of its glycoside 
hydrolases directed to such glycans. This is compar-
able to the CAZyme repertoire detected in the mucin 
specialist A. muciniphila (Table S1). Even though the 
A. mucolyticum CAZyme repertoire is largely direc-
ted toward mucin glycans, A. mucolyticum can also 
use dietary-derived polysaccharide inulin as 
a substrate for growth (Figure S1). This gives the 
bacterium the ability to switch between dietary- and 
host-derived glycans and adapt to fluctuations in 
nutrient availability as encountered in the dynamic 
environment of the gastrointestinal tract.
The plasticity of the CAZyme expression in 
response to changes in the nutritional environ-
ment is also evident from our proteomics analysis. 
This reveals that A. mucolyticum produces 
a limited set of CAZymes in basal medium, that 
contains no source of glycans. Under this condi-
tion, which allows for minimal growth, four 
CAZymes were found to be significantly enriched 
in the conditioned medium as compared to the 
whole cell lysate. The four enzymes (Allo_589, 
898, 1556 & 2010) are a putative α-fucosidase, 
a carbohydrate esterase, a β-galactosidase and 
a N-acetyl-β-galactosaminidase, respectively. 
Although the protein function and exact specifi-
city of CAZymes are difficult to predict based on 
their amino acid sequence alone, the putative 
Figure 6. A. mucolyticum uses mucin O-glycan monosaccharides as a substrate for growth. A. mucolyticum growth was assessed over 
a 72 h period by measuring optical density at 600 nm (OD600). Bacteria were grown in Gut Microbiota Medium (GMM), basal medium 
(BM) or basal medium supplemented with individually added monosaccharides (20 mM). Graphs depict the mean values ± SD acquired 
from three independent experiments.
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annotation suggests that under nutrient limited 
conditions A. mucolyticum is able to hydrolyze 
several host-associated glycans. For example, 
fucose is known to be abundant on mucin glycans, 
but also on glycans such as the Lewis antigens, 
which are known to play a role in regulating 
inflammation.21 The N-acetyl-β- 
galactosaminidase (GH123) could be involved in 
the degradation of glycospingholipids on the 
membranes of the intestinal epithelial cells.22
When basal medium was supplemented with 
either mucin or the GMM carbohydrates glucose, 
fructose and the α- and β-glucans maltose and 
cellobiose, production and secretion of 
CAZymes – in particular O-glycan targeting 
CAZymes – by A. mucolyticum was markedly 
increased. These results indicate that 
A. mucolyticum requires the presence of environ-
mental glycans as stimuli to induce expression and 
secretion of the repertoire of glycosidases. Such 
regulatory mechanisms are also known from other 
bacteria that forage on mucin glycans.4 While we 
have not yet determined in detail the individual 
components responsible for the induction of the 
CAZymes, the fact that both mucin and the combi-
nation of glucose, fructose, maltose and cellobiose 
are sufficient for glycosidase expression suggests 
that a similar glycosidase program is initiated by 
glycans of both host and dietary origin.
The annotation and detection of secreted 
O-glycan targeting CAZymes did not in all 
cases translate to the detection of the predicted 
enzymatic activity. For example, while three 
putative fucosidases were identified within the 
conditioned medium of A. mucolyticum by 
mass spectrometry, no detectable fucosidase 
activity was observed in the conditioned med-
ium using the monovalent 4-MU-fucose fluores-
cent substrate even though the validity of the 
assay was confirmed with a commercial fucosi-
dase. Nor could fucosidase activity be detected 
using a novel activity-based probe. Although it is 
possible that all three fucosidases were annotated 
incorrectly by the dbCAN2 pipeline, the lack of 
detectable fucosidase activity is perhaps more 
likely explained by an incompatibility between 
the substrate specificity of the A. mucolyticum 
fucosidases and the monovalent substrates used 
in this study, as monovalent substrates are struc-
turally different than the complex plant- and 
host-derived glycans found in the intestine.
In contrast to the lack of detectable levels of fuco-
sidase activity, we were able to detect N-acetyl-α- 
galactosaminidase activity, which was not expected 
on basis of the CAZyme annotation (Table 1). This 
might indicate that A. mucolyticum is capable of 
hydrolyzing the α-linked GalNAc moiety that makes 
up the core of O-glycans, thereby enabling the com-
plete degradation of mucin glycans. This hypothesis is 
supported by the finding that A. mucolyticum can 
effectively utilize GalNAc for growth (Figure 6). The 
enzyme(s) responsible for the N-acetyl-α- 
galactosaminidase activity remain to be identified.
Crost et al.23 have previously demonstrated that the 
ability of R. gnavus to grow on PGM as a sole carbon 
source is strain-dependent, and was due to the pre-
sence of sialidases and fucosidases. These results high-
light the necessity for both types of glycosidases to 
remove the terminal sialic acid and fucose residues 
in order to allow degradation and subsequent utiliza-
tion of the underlying glycans. A. mucolyticum pro-
duces multiple sialidases and fucosidases that are 
suspected to be essential to access mucin glycans for 
growth. Media supplemented with sialic acid or 
fucose, however, were not able to support growth 
(Figure 6), which is in agreement with the absence of 
core genes in the A. mucolyticum genome normally 
found in canonical gene clusters for sialic acid or 
fucose catabolism. Interestingly, a curated blast search 
of the genome does show the presence of several genes 
predicted to be involved in the uptake of sialic acid, 
like genes encoding for sialic acid TRAP transporter 
SiaQ and sialic acid-binding protein SiaP (Allo_00009 
and Allo_00087, respectively).24 Furthermore, there 
are several putative polysialyltransferases (e.g. 
Allo_01518 and Allo_02009) with homology to pro-
teins from Neisseria meningitidis known to play a role 
the sialylation of lipooligosaccharide (LOS). 
Sialylation of the bacterial LOS or capsule glycans is 
known to contribute to host colonization and bacterial 
immune evasion.25,26 When A. mucolyticum does not 
directly use host glycan-liberated sialic acid or fucose, 
they could still have a major impact on the ecology of 
the mucosal niche and host health as free sialic acid 
and fucose has been shown to boost the expansion of 
enteric pathogens like Salmonella typhimurium, 
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Clostridium difficile, Campylobacter jejuni and 
Escherichia coli under certain conditions.27–30 In addi-
tion to this, removal of sialic acid from mucin glycans 
was shown to affect rotavirus adhesion and 
infection.31,32 Whether A. mucolyticum decorates its 
surface glycans with endogenous sialic acid or fucose, 
or affects the microbiota composition indirectly by 
releasing them into the environment remains to be 
investigated.
Increased bacterial penetration and degradation 
of the intestinal mucus layer are major features of 
IBD. Understanding the mechanisms that drive 
these processes may thus be key to treating or pre-
venting disease. It has been reported that a diet 
deprived of dietary fiber enhances the expression of 
mucin targeting CAZymes of the gut microbiota and 
promotes the expansion of mucus degrading bacteria 
such as A. muciniphila and Bacteroides caccae.33 As 
mucin also seems to be an important nutrient source 
for A. mucolyticum, it may be that a similar expan-
sion might be observed for this bacterium. Bacterial 
mucus degradation may cause erosion of the mucus 
layer and an increased susceptibility to lethal colitis 
by the enteric pathogen Citrobacter rodentium, as 
was shown in mice.33 This finding highlights the 
delicate balance between the microbiota, an intact 
mucus layer and invading pathogens.
Mucus layer degradation, as observed in IBD 
patients, is linked to an increased prevalence 
mucosa-associated mucolytic bacteria, like 
R. gnavus and R. torques.34 Since A. mucolyticum 
was isolated from a patient with ulcerative colitis 
and, as described here, is able to effectively forage 
on mucins, it is likely that it operates in the same 
niche as other mucolytic bacteria. It would there-
fore be of great interest to investigate the interac-
tions with other known mucus-degrading bacteria 
and to investigate to what extent the mucolytic 




All commercial chemicals were purchased from 
Sigma-Aldrich unless stated otherwise. Data visua-
lization was performed using Adobe Illustrator 
2021, GraphPad Prism 7, and R.
Carbohydrate-active enzyme (CAZyme) annotation
CAZymes within the Prokka-annotated genome of 
A. mucolyticum (Genbank accession number: 
JAHUZH010000000) and A. muciniphila ATCC 
BAA-835 (NCBI Reference Sequence: 
NC_010655.1) were annotated using the dbCAN2 
metaserver (http://bcb.unl.edu/dbCAN2/) in 
February 2021.20,35 CAZymes identified by at least 
two out of three tools were considered for further 
analysis and are displayed in Figure 1. The putative 
mucin-targeting glycoside hydrolases, as displayed 
in Table 1, Figure 2, and supplementary STable 1, 
were selected based on the mucin targeting 
CAZyme classes reported by Tailford et al.6
Mucin and mucin O-glycan purification
Porcine gastric mucin (PGM type III, Sigma– 
Aldrich) was purified by ethanol precipitation as 
described previously by Ottman et al.36 with minor 
modifications. Briefly, 10 g of mucin was dissolved 
in 500 ml 2X PBS with pH 7.8 (NaCl: 274 mM, KCl: 
5.4 mM, Na2HPO4: 20 mM, KH2PO4: 3.6 mM) and 
100 µL of toluene for 24 h at 4°C, under continuous 
stirring. After the first hour, the pH was adjusted to 
7.2 with 2 M NaOH. After 24 h, the solution was 
centrifuged at 10,000 x g for 20 min at 4°C, after 
which the supernatant containing the dissolved 
mucin was collected, cooled to 0°C and ice-cold 
(0°C) ethanol was added to a final concentration 
of 60% (vol/vol). The resulting precipitate was dis-
solved in 0.1 M NaCl and precipitated again with 
ice-cold ethanol to 60% (vol/vol). The precipitate 
was then washed with 100% ice-cold ethanol and 
dissolved in distilled water (~180 mL). Thereafter, 
the mucin solution was dialyzed against 5 L of 
distilled water for 24 h at 4°C, lyophilized, resus-
pended in Milli-Q ultrapure water, and sterilized by 
autoclaving (15 min at 121°C).
Porcine gastric mucin O-glycans were purified 
according to a protocol by Desai et al.33 In short, 
PGM (Type III, Sigma-Aldrich) was suspended at 
2.5% w/v in 100 mM Tris (pH 7.4) and autoclaved 
immediately (15 min at 121°C). Proteinase 
K (Sigma) was added to a final concentration of 
100 µg/mL and incubated for 16 h at 55°C with slow 
shaking. The proteolyzed solution was centrifuged 
at 21,000 x g for 30 min at 4°C to remove insoluble 
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material. Next, NaOH and NaBH4 were added to 
final concentration of 0.1 M and 1 M, respectively. 
This solution was incubated for 18 h at 65°C to 
promote selective release of mucin O-glycans from 
mucin glycopeptides by alkaline β-elimination. The 
solution was neutralized to pH 7.0 with 2 M HCl, 
centrifuged at 21,000 x g for 30 min at 4°C, and 
filtered with a 0.2 µm filter to remove remaining 
insoluble material. After extensive dialysis (4 x 4 h 
with a 100X volume of Milli-Q Ultrapure water, 1 
kDa MWCO dialysis tube), the dialyzed mucin 
O-glycan solution was lyophilized and resuspended 
in Milli-Q Ultrapure water at desired 
concentrations.
Human small intestinal mucins were harvested 
from the urine (~100 mL per batch) of a patient 
with an orthotopic neobladder reconstruction. 
Crude mucin was collected by centrifugation 
(30,000 x g, 4°C, 30 min) and pellets were washed 
twice with PBS. Washed mucin was purified further 
using ethanol precipitation, as described for PGM, 
and redissolved in 5 mL Milli-Q Ultrapure water. 
Instead of lyophilization, the mucin was directly 
transferred to a 100 kDa MWCO Amicon Ultra 
filter (Thermo Fisher Scientific), washed twice 
with 5 mL Milli-Q and concentrated. Protein con-
centration was determined using a NanoDrop One 
UV-Vis Spectrophotometer (Thermo Fisher 
Scientific) and set to 10 mg/mL in Milli-Q 
Ultrapure water.
Bacterial culture conditions
A. mucolyticum was routinely cultured at 37°C 
under anaerobic conditions in a vinyl anaerobic 
chamber (Coy Labs) with the following gas mix: 
85% N2, 10% CO2 and 5% H2. Gut Microbiota 
Medium (GMM) (Table S2), was the default growth 
medium and is essentially an enriched Gut 
Microbiota Medium, as described by Goodman et -
al.37 that lacks isovaleric acid. The basal medium 
(BM) is GMM lacking glucose, fructose, maltose 
and cellobiose. Prior to use for bacterial growth, 
all media were prereduced in the anaerobic cham-
ber for at least 12 h.
Bacterial growth curves
Gut Microbiota Medium and basal medium were 
prepared according to recipe in described in Table 
S2. All media supplements were prepared in Milli- 
Q Ultrapure water and, if required, solutions were 
brought to neutral pH using 1 M NaOH. 
Supplemented media were prepared with supple-
ments at following final concentrations: D+ glucose 
(2 mg/ml, Sigma), D-fructose (1 mg/mL, Sigma), D 
+ maltose (1 mg/ml, Sigma), D+ cellobiose (1 mg/ 
ml, Sigma), N-Acetylneuraminic acid (20 mM, 
Carbosynth), L-Fucose (20 mM, Sigma), D 
+ Galactose (20 mM, Mikrobiologie), N-acetyl- 
D-glucosamine (20 mM, Sigma), N-acetyl- 
D-galactosamine (20 mM, Carbosynth), inulin 
(10 mg/mL, Sigma), purified porcine gastric 
mucin (PGM, 0,5% w/vol) or purified PGM 
O-glycans (10 mg/mL). All solutions, except PGM 
solution, were filter-sterilized and prereduced in 
the anaerobic chamber prior to use
A. mucolyticum was grown on GMM agar 
plates for 72 h at 37°C under anaerobic condi-
tions. Static liquid starter cultures were inocu-
lated with three separate bacterial colonies each 
and grown for 16 h at 37°C under anaerobic 
conditions. Bacterial growth was assessed by 
measuring absorbance (600 nm). Bacteria were 
collected by centrifugation (3,000 x g, 5 min), 
gently washed twice and resuspended in 2X basal 
medium. Washed bacteria were diluted to the 
desired OD and combined with an equal volume 
of MilliQ Ultrapure water or medium supple-
ments to a total volume of 200 µL per well 
with a final starting OD of 0.01. For each time 
point (0, 8, 16, 24, 32, 48 and 72 h) a 96-Well 
Multiwell Plate (Corning Costar) was used with 
duplicate wells per condition. At each time point 
one plate was removed from the anaerobic 
chamber and final absorbance values (600 nm) 
were recorded using a FLUOstar Omega plate 
reader (BMG Labtech). Values were corrected 
for background levels in respective negative con-
trols. Experiments were performed in triplicates, 
using three biologically independent 
A. mucolyticum starter cultures.
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Bacterial conditioned media and whole cell lysate 
preparation
Bacterial conditioned media and whole-cell lysates 
for mass spectrometric analysis were harvested 
from static liquid A. mucolyticum cultures that 
were grown in Gut Microbiota Medium, basal med-
ium or basal medium supplemented with 0.5% 
PGM for 24 h at 37°C under anaerobic conditions. 
For each condition, 4 mL cultures were inoculated 
from three independent starter cultures and grown 
as described above. After 24 h, bacteria were har-
vested by centrifugation at 15,000 x g for 2 min, 
washed twice with 2 mL of PBS and resuspended in 
4 mL of ice-cold lysis buffer (PBS containing 
cOmplete EDTA-free protease inhibitor cocktail 
(Roche)). The conditioned media were collected 
and filter-sterilized using 0.2 µm filter. Bacteria 
were lysed by sonication (3 x 10 seconds on ice). 
Large bacterial fragments were removed by centri-
fugation at 15,000 x g for 1 min, after which cleared 
lysate was collected. To remove possible media 
components all bacterial cell lysates and condi-
tioned media were transferred to a 5 kDa MWCO 
filter (Pierce concentrator, PES, 5 K MWCO, 6 ml, 
Thermo Fisher Scientific), washed with 5 mL of 
Milli-Q and concentrated to 1 mL.
The conditioned media used for glycosidase enzy-
matic activity assays were collected from three inde-
pendent static liquid A. mucolyticum cultures grown 
in the Gut Microbiota Medium for 48 h at 37°C 
under anaerobic conditions. The conditioned media 
were filter-sterilized using 0.2 µm filter and stored at 
−20°C prior to use. The 100X concentrated condi-
tioned media used for fucosidase assays were 
obtained using a 10 kDa MWCO Amicon Ultra 
filter (Thermo Fisher Scientific).
Mass spectrometry sample preparation
Whole cell lysates and conditioned media were pro-
cessed using Filter Aided Sample Preparation (FASP), 
as described by Wiśniewski et al.38 In brief, samples 
were denatured at 95°C in the presence of DTT, 
mixed with 8 M urea and loaded onto Centrifugal 
Filters (Microcon, cat. no MRCF0R030). This was 
followed by two washes with 8 M urea, treatment 
with 0.05 M iodoacetamide in 8 M urea, and three 
8 M urea washes. After washing out the urea with 
three washes with 0.05 M ammonium bicarbonate, 
samples were digested overnight with trypsin at 37°C. 
The next day, samples were acidified and desalted 
using Stagetips.39 Half of each of the digested samples 
was injected into an LTQ-Orbitrap QExactive mass 
spectrometer (Thermo Fisher Scientific) and mea-
sured using a 120-minute gradient.
Mass spectrometry analyses
Thermo Raw files were analyzed using MaxQuant 
versions 1.5.1.0 using default parameters, with the 
inclusion of the match between runs and IBAQ 
features.40,41 Initial analyses were performed in 
Perseus.42 Proteins flagged as contaminants, reverse 
or only identified by site were filtered out. 
Triplicates were grouped and only proteins repro-
ducibly quantified in at least one of the sets of 
triplicates were retained. Missing values were 
imputed using default parameters. Differential pro-
teins were determined using a t-test with adjustment 
for multiple testing (FDR < 0.05). To call proteins 
enriched in the secreted fractions, they additionally 
required at least a 10-fold higher LFQ value com-
pared to the whole cell lysates. Data visualization 
and downstream processing was performed in R.
Glycosidase activity assays
A. mucolyticum conditioned media used for enzymatic 
assays were collected as described above. The following 
substrates were used: 4-MU-Neu5Ac (Cayman), 
4-MU-Fucose (Carbosynth), 4-MU-GlcNAc 
(Carbosynth), 4-MU-GalNAc (Carbosynth), and 
ortho-Nitrophenyl-β-galactoside (ONPG, Sigma). 
Stocks of the 4-MU linked substrates were diluted to 
200 µM in Milli-Q Ultrapure water and ONPG was 
diluted to 1 mg/mL in Milli-Q Ultrapure water, after 
which 50 µl of diluted substrates were added to a 96- 
Well Multiwell flat-bottom Plate (Corning Costar). 
Next, 50 µL of either the Gut Microbiota Medium 
(negative control), conditioned medium or heat- 
inactivated conditioned medium (98°C for 30 min) 
were added in duplicates. Plates were incubated for 2 
h at 37°C shielded from light and transferred to 
a FLUOstar Omega plate reader (BMG labtech). For 
the 4-MU linked substrates, signal was detected using 
a 340 ex./460 em. filter set. For the ONPG substrate, 
absorbance was measured at a wavelength of 420 nm.
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Chemoselective labeling of fucosidases using an 
activity-based probe was performed as described by 
Luijkx and Henselijn et al.43
Detection of mucin degradation by Periodic 
acid-Schiff (PAS) stain and western blotting
PGM or human mucin (10 mg/mL in Milli-Q 
Ultrapure water) were combined at a 1:1 ratio 
with medium controls or the same 
A. mucolyticum conditioned medium that was 
used for the glycosidase activity assays. This 
mixture was incubated for 16 h at 37°C after 
which samples were mixed with one volume of 
3x Laemmli sample buffer and boiled for 5 min. 
Subsequently 25 µL per sample was loaded onto 
a gel and separated using SDS-PAGE. For SDS- 
PAGE separation and immunoblotting of large 
mucin proteins, a Boric acid-Tris gel system 
was used, as previously described by Li et al,44 
with minor modifications. A 5% acrylamide gel 
(5% Acryl/Bis acryl solution, Bio-Rad 161–0144; 
26% 1.5 M Tris pH 8.8; 0.1% SDS; 0.1% ammo-
nium persulfate; 0.1% TEMED) was prepared in 
a Mini Protean II chamber (Bio-Rad) using 
1.5 mm spacer plates. Gels were run in Boric 
acid-Tris buffer (192 mM Boric acid; 1 mM 
EDTA; 0.1% SDS, set to pH 7.6 with Tris) at 
25 mA per gel for 3 h. To detect glycoproteins, 
gels were stained using a Periodic acid-Schiff 
stain (Pierce glycoprotein staining kit, Thermo 
Fisher Scientific). For detection of MUC2 and 
sialic acids, mucins were separated as described 
above and transferred onto nitrocellulose mem-
branes using a wet transfer system with transfer 
buffer (25 mM Tris; 192 mM glycine; 20% 
methanol,) for 3 h at 90 V at 4°C. 
Subsequently, membranes were blocked with 
5% bovine serum albumin (BSA, Sigma- 
Aldrich) in TSMT buffer (20 mM Tris, 
150 mM NaCl, 1 mM CaCl2, 2 mM MgCl2, 
0.1% Tween 20, adjusted to pH 7 with HCl) 
overnight at 4°C and then incubated with an 
anti-human MUC2 rabbit serum (a gift from 
Dr. Karin Strijbis) at a 1:200 dilution in 
TSMT containing 1% BSA, or with biotinylated 
SNA lectin (2 mg/mL stock, Vector Labs) at 
a dilution of 1:1000 in TSMT containing 1% 
BSA. After incubation for 1 h at room 
temperature, blots were washed 4 times with 
an excess of TSMT and incubated with α- 
rabbit IgG (A4914, 1:10,000 dilution, Sigma- 
Aldrich) in TSMT containing 1% BSA for the 
detection of MUC2, or Streptavidin-HRPO 
(1 mg/ml stock, 1:10,000 dilution, Jackson 
ImmunoResearch) in TSMT containing 1% 
BSA for the detection of sialic acids. Blots 
were developed with the Clarity Western ECL 
kit (Bio-Rad) and imaged in a Gel-Doc system 
(Bio-Rad).
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